Lung cancer is the most prevalent carcinoma and the leading cause of cancer death worldwide. Approximately 85%-90% of lung cancer diagnoses are non-small-cell lung cancer (NSCLC), including lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC). A remarkable proportion of cases are only detected in the advanced stage when the tumour has already metastasized to other organs, resulting in poor clinical prognosis. 1,2 Epithelial-mesenchymal transition (EMT) is generally considered to be the key progression promoting the metastasis of lung cancer. 3 Thus, elucidating the molecular mechanism of EMT is of great significance in preventing lung cancer metastasis and progression.
Nicotinic acetylcholine receptors (nAChRs) are widely distributed in various types of cancer cells, including lung, breast, pancreas, stomach and gliomas, and regions where there are ligand-gated ion channels. 4 Nicotinic acetylcholine receptors comprise pentameric subunits using various combinations of alpha (α1-α10) or non-alpha (β1-β4, γ, δ, or ε) types. 5 Nicotinic acetylcholine receptors are classified into two categories, heteromeric and homomeric nAchRs. 6 Heteromeric nAChRs contain a combination of α and β subunits.
Homomeric nAChRs are composed of five α subunits (α7, α8 and α9). 7 Previous studies have demonstrated that nAChRs play an important role in mediating the stimulation of tumour cell proliferation, migration, invasion and EMT of lung cancer. 8, 9 Different subunits of nAChRs are expressed in different tissues and organs. 10, 11 Among different members of nicotinic receptor family, the intracellular domain of α7 nAChR is one of the most well conserved, and the role of α7-nAChR in non-neuronal systems has been predominantly studied. 12 However, nAChR subunits and downstream signalling pathways vary from different types of NSCLC. 13 Notably, genome-wide association studies (GWAS) have showed that variants in the region encoding the α3, β4 and α5 subunits of nAChRs are significantly involved in nicotine dependence and lung carcinogenesis. 14 Especially, α5-nAChR was highly associated with lung cancer risk and nicotine dependence. 15, 16 Here, we have focused on the role of α5-nAChR in the development and progression of lung cancer.
Recently, our laboratory demonstrated that α5-nAChR mediates nicotine-induced lung cancer development and progression. 17 Nicotine interacts with α5-nAChR on the cell surface, activating the JAK2/Stat3 signalling pathways and promoting lung cancer cell proliferation. 18 Furthermore, α5-nAChR mediates nicotine-induced lung cancer cell migration and invasion. 19 Nevertheless, the mechanism by which α5-nAChR functions in lung cancer EMT remains to be elucidated. Jab1 was originally identified as a c-Jun coactivator and was subsequently shown to be the fifth member of the constitutive photomorphogenic-9 (COP9) signalosome (CSN) complex (COPS5 or Csn5, commonly known as Jab1; Jab1 hereafter). 20 Increasing evidence indicates that Jab1 activity mediates various tumorigenesis-associated pathways 21 and is a potential target for smoking-induced lung cancer. 22 P-Stat3 regulates the progression of nasopharyngeal and breast cancer by activating Jab1, 23, 24 which regulates the expression of ZEB1 and affects the EMT process in renal cancer cells (RCCs). 25 Notably, the down-regulation of Jab1 decreases PD-L1 expression in cancer cells and sensitizes them to anti-CTLA4 therapy. 26, 27 Thus, understanding the regulation of α5-nAChR and Jab1 expression has major clinical relevance.
In this study, we assessed α5-nAChR and Jab1 expression in LUAD and demonstrated that Jab1 expression is positively associated with α5-nAChR levels in vivo. Furthermore, α5-nAChR mediates the EMT and metastasis of NSCLC cells via Stat3/Jab1 signalling in LUAD. To the best of our knowledge, this is the first study to show that the α5-nAChR/Jab1 signalling axis is involved in lung cancer EMT and metastasis, which may represent a plausible tumour-targeting strategy in lung cancer. 
| MATERIAL S AND ME THODS

| Tissue specimens and cell cultures
| Clinical cDNA microarray analysis of the correlations between CHRNA5 and Jab1 (COSP5) using relevant databases
The expression patterns of α5-nAChR and Jab1 (COSP5) in TCGA LUAD (n = 515) and normal tissues (n = 59) were analysed using the Ualcan online database (http://ualcan.path.uab.edu/index.html). The correction between the expression of CHRNA5 and Jab1 (COSP5) in NSCLC was analysed using the R2 online database (http://r2.amc.nl).
The correlation between CHRNA5 and/or Jab1 (COSP5) expression and the cancer patients' overall survival in TCGA LUAD dataset was analysed using R2: Kaplan Meier Scanner (Pro) (https ://hgser ver1.
amc.nl/cgi-bin/r2/main.cgi).
| In vivo proliferation and metastasis assays
All animal experiments were approved by the Animal Care and Use Committee of Jinan Central Hospital affiliated to Shandong University. BALB/c athymic nude mice (4-6 weeks old) were used for all in vivo studies. To induce ectopic tumour, 2 × 10 6 cells suspended in 100 mL of medium were subcutaneously injected into right flank of the mice (n = 6). Tumour size was measured every 3 days, and the volume was determined as follows: length × width 2/2. To ascertain the role of α5-nAChR in tumour metastasis, 2 × 10 6 cells suspending in 100 μL medium were intravenously injected into the lateral tail vein of nude mice. All mice were killed by cervical vertebra dislocation. The tumour xenografts and the lung were collected and analysed by immunohistochemistry.
| Immunohistochemistry
Tissue sections (4 µm thickness) were analysed and detected by immunohistochemical staining using the streptavidin peroxidase method (S-P method expression, ≤10% of the positively stained cells; and moderate and strong expression, >10% of the positively stained cells. Weak expression was rated as negative, and moderate and strong expressions were rated as positive.
| siRNA interference and lentiviral transfection
siRNAs for CHRNA5 (encoding α5-nAChR), Jab1, Stat3 and the negative control were obtained from GenePharma. Transient transfection of A549 and H1299 cells was performed using the Oligofectamine 2000 (Invitrogen) protocol and 5-nmol siRNAs in RPMI supplemented with 10% FBS and no penicillin or streptomycin as described previously. 18 Human CHRNA5 cDNA was subcloned into a pGV-puro lentiviral vector containing the puromycin resistance to establish stable A549 and H1299 (Genechem) cell lines to induce α5-nAChR overexpression (marked as α5-nAChR + ). Stable
A549 and H1299 cells were selected by incubating cells in medium
supplemented with puromycin for 48 hours after transfection.
| Western blot analysis
Cell monolayers were lysed in RIPA buffer as previously described. 28 The primary antibodies used in this study included α5-nAChR Proteintech Group, Inc). GAPDH served as an internal standard.
| Wound healing assay
Monolayers of A549 or H1299 cells in the 6-well plates were wounded by scratching the surface. The wells were rinsed three times with phosphate-buffered saline (PBS) and incubated at 37°C for 48 hours. The movements of A549 or H1299 cells in the scratched area were photographed by using an Olympus CKX41 microscope. The healing width was calculated from 0 to 48 hours and normalized to the control group.
| Cell invasion assay
The invasion assay was performed using a 24-well Transwell chamber (Corning, USA). A549 or H1299 cells were seeded at a density of 1 × 10 5 cells into the upper chamber with an 8 mm pore size insert (Corning, USA). The wells of the plate were filled with 600 mL of RPMI1640 supplemented with 20% FBS. A549 or H1299 cells on the upper side of the membrane were removed using clean swabs, and cells on the underside were viewed and counted after incubation for 48 hours at 37°C. A549 or H1299 cell invasion was quantified using an inverted-contrast microscope.
| Statistical analysis
The data are presented as the means ± SDs and were analysed using SPSS v22.0 (SPSS). Student's t test was used to assess the significance of the differences between groups. Spearman's correlation analysis was used to analyse the association between α5-nAChR and Jab1 proteins in NSCLC. The differences were considered significant if P was <.05.
| RE SULTS
| CHRNA5 and Jab1 (COSP5) expression and poor prognosis are correlated in NSCLC patients
CHRNA5 and Jab1 (COSP5) expression was increased in the TCGA LUAD subset (n = 515) compared to that observed in the control group using the Ualcan online database (http://ualcan.path.uab.edu/index. html) ( Figure 1A ). The R2 online database (http://r2.amc.nl) was used to analyse the correlation between CHRNA5 and Jab1 (COSP5) expression in the TCGA LUAD (n = 515) and NSCLC Hou subsets (n = 156). The data showed that CHRNA5 and Jab1 (COSP5) expressions were positively correlated ( Figure 1B) . The survival analysis using TCGA LUAD subset from R2: Kaplan Meier Scanner (Pro) (https ://hgser ver1.amc.
nl/cgi-bin/r2/main.cgi) showed that high CHRNA5 or Jab1 (COSP5) expression correlated with poor prognosis ( Figure 1C ). Furthermore, CHRNA5 and Jab1 (COSP5) levels are elevated accompanied by poor prognosis only in smokers and not in non-smokers ( Figure S1 ).
We previously reported that CHRNA5 expression is significantly associated with overall survival. 18 In this study, we examined α5-nAChR and Jab1 expression in 18 NSCLC and 18 para-carcinoma tissue samples via immunohistochemistry analysis. The results showed that α5-nAChR was overexpressed in lung cancer tissue (72.2%, 13/18). Consistently, the positive rate of Jab1 in the lung cancer tissue samples (66.7%, 12/18) was higher than that observed in the para-carcinoma tissue samples ( Figure 1D , Table 1 ). There was a correlation between the expression of α5-nAChR and that of Jab1 in lung cancer. These data suggest that α5-nAChR and Jab1 expressions are potential prognostic biomarkers in lung cancer.
| α5-nAChR and Jab1 expressions are correlated in NSCLC tumour xenografts
As α5-nAChR expression was observed to be associated with Jab1 expression in lung cancer patient samples, we further assessed α5-nAChR and Jab1 expressions in NSCLC xenograft tissues. As we previously reported, 17 the tumour volumes of α5-nAChR knockdown xenografts (KD) were smaller than those of the xenografts derived from control cells (NC) (Figure 2A ). The immunohistochemistry assay showed that the expression of α5-nAChR and Jab1 was higher in the NC group compared to that observed in the sh-CHRNA5 tumour group ( Figure 2B) . These results suggested that α5-nAChR is associated with Jab1 expression in NSCLC carcinogenesis.
| α5-nAChR expression mediates that of Stat3, Jab1, N-cadherin and Vimentin in A549 and H1299 cells
Based on the observed correlation between α5-nAChR and Jab1 expression in vivo, we further explored the association between and treatment time of nicotine on A549 and H1299 cell proliferation are both 1 μM for 16 hours. 28 The expression of α5-nAChR and Jab1 expressions was detected in A549 and H1299 cell lines treated with 1 and 10 µM nicotine for 16 hours, and the results showed that α5-nAChR and Jab1 exhibited increased expression at the protein level compared to that observed in the control ( Figure 3B ). 
| α5-nAChR/Stat3 signalling mediates Jab1 expression in A549 and H1299 cells
We cultured A549 and H1299 cells and transfected them with si-NC, si-CHRNA5, si-Stat3 or si-CHRNA5 + si-Stat3 fragments to study the correlation between α5-nAChR/Stat3 and Jab1. As show in Figure 4A , silencing of α5-nAChR decreased the levels of p-Stat3 and Jab1 (P < .05), which is generally consistent with the results of our previous study. 18 Furthermore, silencing Stat3 decreased the levels of α5-nAChR and Jab1 (P < .05). It is worth noting that compared to si-CHRNA5 cells and si-Stat3 cells, the expression of α5-nAChR and Jab1 was lower in si-CHRNA5 + si-Stat3 cells (P < .05). Similar results were also observed in the H1299 cell line ( Figure 4B ). These results are consistent with those of our former study showing that there is a feedback loop between α5-nAChR and Stat3, and also demonstrate that α5-nAChR/Stat3 signalling mediates Jab1 expression in NSCLC cells.
| α5-nAChR and Jab1 regulate lung cancer cell migration and invasion
Migration and invasion are closely associated with cancer cell metastasis. To evaluate the effects of α5-nAChR and Jab1 on the migration and invasion of NSCLC cells, wound healing and transwell assays were performed. The wound healing assay results showed that increased α5-nAChR expression in A549 cells was associated with a significantly faster wound closure, while silencing α5-nAChR by si-CHRNA5 resulted in slower wound healing compared to that observed in the control ( Figure 5A ). These assays were performed using H1299 cells ( Figure 5B ). In addition, we transfected cells with si-Jab1 to study the role of Jab1 in cell migration. Compared to the control cells, si-Jab1-transfected A549 and H1299 cells migrated more slowly to repair the wounds ( Figure 5C ).
We performed transwell assays to further verify the role of Figure S2 ), which confirmed that α5-nAChR involved in lung cancer metastasis.
| D ISCUSS I ON
The results of our previous study showed that nicotine-induced activation of JAK2/Stat3 signalling was inhibited by the silencing of α5-nAChR. ChIP assays confirmed that the CHRNA5 promoter The role of nAChRs has been intensely studied in the growth, angiogenesis and metastasis of lung cancer. 13, 30 The reason for this trend is due to GWAS studies showing genetic variations in α5-α3-β4 nAChR cluster (CHRNA5-CHRNA3-CHRNB4) associated with increased risk of death from lung cancer, COPD and tobacco-related cancers. 14, 31 Conventionally, the α7-nAChR is thought to mediate the proliferative, pro-angiogenic and pro-metastatic activity of nicotine in lung cancer. 32 Other genomic variances near CHRNA2 gene were correlated to increased overall risk for developing lung cancer. 33 Such observations underscore the role for different nAchR subunit in the development and progression of lung cancer. However, the mechanism of various nAchR subunit in lung cancer is far to know. 34 It is well known that nAChRs function as ligand-gated cationic channels, and their activation by nicotine promotes an influx of Ca 2+ and activation of voltage-gated Ca 2+ channels. 35 Subsequently, various signalling pathways are activated, such as Wnt/-catenin, Ras/Raf/MEK/ERK, PI3K/Akt and JAK2/ Stat3, leading to the promotion of tumour cell proliferation, EMT and migration. [36] [37] [38] [39] [40] Nicotine and its derivatives such as NNK and NNN, can not only activate nAChRs, studies have also shown that lung cancers synthesize acetylcholine (ACh) and cytokines, which acted as autocrine growth factors that stimulate nAChRs in lung cancer despite a lack of exogenous nicotine. 41, 42 EMT is a key initiating event in the metastatic cascades of various cancers. [43] [44] [45] The molecular mechanism of α5-nAChR in lung cancer EMT is far from clear. In this study, we showed that the expression of α5-nAChR mediates Stat3/Jab1 signalling and promotes EMT by up-regulating N-cadherin and Vimentin expression. Furthermore, α5-nAChR activation promoted tumour invasion and metastasis in A549 and H1299 cells, validating our in vivo observations. These results suggest that the expression of α5-nAChR promotes EMT and metastasis by regulating the Stat3/Jab1 signalling pathway in NSCLC.
Jab1 is a tumour oncogene in a variety of human cancers 46, 47 and has been shown to be a key molecule in nicotine-induced lung cancer. 48, 49 Remarkably, Csn5/Jab1 mediates stabilization of PD-L1, which is crucial for breast cancer cells to escape immune surveillance via PD-L1/PD-1 interaction. Immune checkpoint-blockade treatments targeting PD-1/PD-L1 have revolutionized various cancers therapy. Thus, Jab1 represents a potential target for the treatment of inflammatory-related cancers. In this study, α5-nAChR expression was shown to be correlated with that of Jab1 in lung cancer in vivo. α5-nAChR/Stat3 signalling mediates Jab1 and EMT molecules in A549 and H1299 cells. The inhibition of α5-nAChR or Jab1 inhibited the migration and invasion of NSCLC. Our results demonstrated that α5-nAChR/Jab1 signalling may be an important mechanism responsible for promoting the EMT, invasion and migration of NSCLC. Thus, targeting α5-nAChR/Jab1 signalling in cancer cells may be a potential strategy for cancer treatment via mediating PD-1/PD-L1 signalling. Based on the results of this study of α5-nA-ChR/Jab1 expression in the EMT and metastasis of NSCLC, further studies will be performed to assay the role of the α5-nAChR/Jab1/ PD-L1 axis in lung cancer immunotherapy.
In summary, we demonstrated that α5-nAChR mediates NSCLC EMT, migration and invasion via Stat3/Jab1. These findings provide new insights into the possible molecular mechanisms by which α5-nAChR and Jab1 mediate lung cancer metastasis. Acetylcholine and its analogue bind to α5-nAChR on the cell surface and activate p-Stat3, which subsequently activates the expression of Jab1 to promote tumour cell EMT and metastasis ( Figure S3 ).
As Jab1 is important for cancer cells to escape immune surveillance by mediating PD-L1/PD-1 interactions, the association between the α5-nAChR/Jab1 axis and PD-L1 requires further study.
Thus, components of the α5-nAChR/Jab1/PD-L1 axis may be useful as potential targets for NSCLC diagnosis and immunotherapy in the future.
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